0.9355
price down icon0.37%   -0.0035
 
loading

Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
153.66%
0.104
0.041 0.243 0.12 0.121
Operating Expenses
24.61%
9.719
12.89 8.07 12.09 14.90
Operating Income/Loss
25.18%
-9.615
-12.85 -7.827 -11.97 -14.78
Nonoperating Income/Loss
24.16%
0.383
0.505 0.611 0.716 0.834
Net Income/Loss
25.22%
-9.232
-12.35 -7.216 -11.26 -13.94
Preferred Stock Dividends And Other Adjustments
0.00%
0.006
0.006 0.007 0.006 0.006
Basic Average Shares
0.07%
68.40
68.35 - 66.88 66.53
Diluted Average Shares
0.07%
68.40
68.35 - 66.88 66.53
Basic Earnings Per Share
22.22%
-0.14
-0.18 - -0.17 -0.21
Diluted Earnings Per Share
22.22%
-0.14
-0.18 - -0.17 -0.21
$5.83
price down icon 1.19%
$8.025
price up icon 3.02%
$8.33
price down icon 0.48%
DNA DNA
$9.665
price down icon 3.45%
$10.52
price down icon 1.96%
$6.18
price down icon 3.59%
Kapitalisierung:     |  Volumen (24h):